Botulinum toxin treatment for spasmodic dysphonia: Percutaneous versus transoral approach

Clinical Neuropharmacology

Volumn 21, Issue 3, 1998, Pages 196-198

  García Ruiz, Pedro J ^a,b   Español, Carlos Cenjor ^a   Bernardos, Vicenta Sanchez ^a   Astarloa, Rosa ^a   Sanabria, Jaime ^a   De Yébenes, Justo García ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Ciudad Universitaria ^*  (Spain)

Author keywords

Botulinum toxin; Device for transoral technique; Focal dystonia; Spasmodic dysphonia; Transoral approach

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEVICE; DOSE RESPONSE; DRUG EFFICACY; DYSPHONIA; FEMALE; FIBEROSCOPE; HUMAN; INJECTION; LARYNX MUSCLE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; INJECTIONS; LARYNGOSCOPY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VOICE DISORDERS;

EID: 18544404206     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jankovic J, Fahn S. Dystonic Disorders. In: Jancovic J, Tolosa E (eds). Parkinson's disease and Movement disorders. Baltimore: Williams & Wilkins, 1993:337-374
2. Ludlow CL. The spasmodic dysphonias: Speech, movement, and physiological characteristics. In: Tsui K C, Calne D B (eds). Handbook of Dystonia. New York: Marcel Dekker, 1995:159-180
3. Aronson AE, De Santo LW. Adductor spasmodic dysphonia: Three years after recurrent nerve resection. Laryngoscope 1983;93:1-8
4. Miller R, Woodson G, Jankovic J. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. Arch Otolaryngol Head Neck Surgery 1987;113:603-605
5. Brin M, Blitzer A, Fahn S, Lovelace R. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia. Laryngoscope 1988;98:193-197
6. Lees AJ, Turjenski N, Rivest J, Whurr R, Lorch M, Brookes G. Treatment of cervical dystonia, hand spasm and laryngeal dystonia with botulinum toxin. J Neurol 1992;239:1-4:
7. Brin MF, Blitzer A, Stewart A, Diamond B, Lovelace RE. Botulinum toxin for spasmodic dysphonia: Double blind placebo controlled assessment of dose and technique. Mov Disord 1995;10:369
8. Ford C, Bless D, Lowery J. Indirect laryngoscopic approach for injection of botulinum toxin in spamodic dysphonia. Otolaryngol Head Neck Surgery 1990;103:752-758
9. Ford C. A multipurpose laryngeal injection device. Otolaryngol Head Neck Surgery 1990;103:135-137
10. Ohly AK, Ceballos Baumann AO, Joussen K, Conrad B. Adductor type laryngeal dystonia: A series with botulinum toxin therapy using transoral injections. Mov Disord 1995;10:400
11. Brookes GB, Whurr R, Barnes C. Adductor laryngeal dystonia: Factors affecting response to treatment. Mov Disord 1995;10:400
12. Zwirner P, Dressler D, Kruse E. Spasmodic laryngeal dyspnea: A rare manifestation of laryngeal dystonia. Mov Disord 1995;10:384